SUMMARYAU/NZ: - NZ5.1M Sales- Engaged a digital marketing...

SUMMARY

AU/NZ:
- NZ5.1M Sales
- Engaged a digital marketing specialist

UK/Europe
- "progressing well in obtaining regulatory approvals across the EU"
- "the Company's products passing the new testing requirements in Germany"

Asia/China
- Established entity in China, to deal direct with customers (no distributor)
- Company will be investing a significant amount to grow both B2B and B2C channels in China
- Regulatory approvals (to hospital grade standard) have been now been received in China and the Company intends to aggressively target the healthcare markets.
- following the United Airlines announcement, a number of Asian airlines are in discussions with the Company about the use of its products in the
aviation sector.

USA/Canada
- Zoono will be launching a new on-line sales website during November to drive B2C salesin the US.
- Animal Health sales also continue to grow in the US
- Chemical reactor has finished completion at $200k cost (on budget)
- Zoono also has new EPA applications underway, which could take several months, following which the Company expects it will be allowed to make COVID related and longevity claims in the US.

India/MENA
- South Africa is performing well with large orders under negotiation
- New Egyptian distributor on board